The Development of Aggressive Cancer: A Possible Role for Sphingolipids

REFERENCES

• Cahill D.P., Kinzler K.W., Vogelstein B., Lengauer C. Genetic Instability and Darwinian Selection in Tumours. Trends Cell Biol. 1999; 9: M57–M60
   PubMed Web of Science ®Google Scholar
• Pettit S.J., Seymour K., O'Flaherty E., Kirby J.A. Immune Selection in Neoplasia: Towards a Microevolutionary Model of Cancer Development. Br. J. Cancer 2000; 82: 1900–1906
   PubMed Web of Science ®Google Scholar
• Compagni A., Christofori G. Recent Advances in Research on Multistage Tumorigenesis. Br. J. Cancer 2000; 83: 1–5
   PubMed Web of Science ®Google Scholar
• Lengauer C., Kinzler K.W., Vogelstein B. Genetic Instabilities in Human Cancers. Nature 1998; 396: 643–649
   PubMed Web of Science ®Google Scholar
• Shayman J.A. Sphingolipids. Kidney Int. 2000; 58: 11–26
   PubMed Web of Science ®Google Scholar
• Liu G., Kleine L., Hebert R.L. Advances in the Signal Transduction of Ceramide and Related Sphingolipids. Crit. Rev. Clin. Lab. Sci. 1999; 36: 511–573
   PubMed Web of Science ®Google Scholar
• Huwiler A., Kolter T., Pfeilschifter J., Sandhoff K. Physiology and Pathophysiology of Sphingolipid Metabolism and Signaling. Biochim. Biophys. Acta 2000; 1485: 63–99
   PubMed Web of Science ®Google Scholar
• Merrill A.H., Jr., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., Riley R.T., Voss K.A., Wang E. Sphingolipids—the Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology. Toxicol. Appl. Pharmacol. 1997; 142: 208–225
   PubMed Web of Science ®Google Scholar
• Riboni L., Viani P., Bassi R., Prinetti A., Tettamanti G. The Role of Sphingolipids in the Process of Signal Transduction. Prog. Lipid Res. 1997; 36: 153–195
   PubMed Web of Science ®Google Scholar
• Kristal B.S., Brown A.M. Apoptogenic Ganglioside GD3 Directly Induces the Mitochondrial Permeability Transition. J. Biol. Chem. 1999; 274: 23169–23175
   PubMed Web of Science ®Google Scholar
• Quillet-Mary A., Jaffrézou J.P., Mansat V., Bordier C., Naval J., Laurent G. Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-Induced Apoptosis. J. Biol. Chem. 1997; 272: 21388–21395
   PubMed Web of Science ®Google Scholar
• Inoki Y., Miura T., Kajimoto T., Kawase M., Kawase Y., Yoshida Y., Tsuji S., Kinouchi T., Endo H., Kagawa Y., Hamamoto T. Ganglioside GD3 and Its Mimetics Induce Cytochrome c Release from Mitochondria. Biochem. Biophys. Res. Commun. 2000; 276: 1210–1216
   PubMed Web of Science ®Google Scholar
• Di Paola M., Lorusso M. Ceramide Interaction with the Respiratory Chain of Heart Mitochondria. Biochemistry 2000; 39: 6660–6668
   PubMed Web of Science ®Google Scholar
• Ghafourifar P., Klein S.D., Schucht O., Schenk U., Pruschy M., Rocha S., Richter C. Ceramide Induces Cytochrome C Release from Isolated Mitochondria. Importance of Mitochondrial Redox State. J. Biol. Chem. 1999; 274(10)6080–6084
   PubMed Web of Science ®Google Scholar
• Huwiler A., Pfeilschifter J., van den Bosch H. Nitric Oxide Donors Induce Stress Signaling via Ceramide Formation in Rat Renal Mesangial Cells. J. Biol. Chem. 1999; 274: 7190–7195
   PubMed Web of Science ®Google Scholar
• Radin N.S. Apoptotic Death by Ceramide: Will the Real Killer Please Stand Up?. Med. Hypotheses 2001; 96–100
   PubMed Web of Science ®Google Scholar
• Hashmi M., Graf S., Braun M., Anders M.W. Enantioselective Depletion of Mitochondrial Glutathione Concentrations by (S)- and (R)-3-Hydroxy-4-Pentenoate. Chem. Res. Toxicol. 1996; 9: 361–364
   PubMed Web of Science ®Google Scholar
• El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J.J., Hannun Y.A. Molecular Cloning and Characterization of a Human Mitochondrial Ceramidase. J. Biol. Chem. 2000; 275: 21508–21513
   PubMed Web of Science ®Google Scholar
• Morell P., Radin N.S. Specificity in Ceramide Biosynthesis from Long Chain Bases and Various Fatty Acyl Coenzyme A's by Brain Microsomes. J. Biol. Chem. 1970; 245: 342–350
   PubMed Web of Science ®Google Scholar
• Seelan R.S., Qian C., Yokomizo A., Bostwick D.G., Smith D.I., Liu W. Human Acid Ceramidase Is Overexpressed But Not Mutated in Prostate Cancer. Genes Chromosomes Cancer 2000; 29: 137–146
   PubMed Web of Science ®Google Scholar
• Oberley T.D., Zhong W., Szweda L.I., Oberley L.W. Localization of Antioxidant Enzymes and Oxidative Damage Products in Normal and Malignant Prostate Epithelium. Prostate 2000; 44: 144–155
   PubMed Web of Science ®Google Scholar
• Fish R.G. Role of Gangliosides in Tumor Progression: A Molecular Target for Cancer Therapy?. Med. Hypotheses 1996; 46: 140–144
   PubMed Web of Science ®Google Scholar
• Pyne S., Pyne N.J. Sphingosine 1-Phosphate Signaling in Mammalian Cells. Biochem. J. 2000; 349: 385–402
   PubMed Web of Science ®Google Scholar
• Kolesnick R.N., Goni F.M., Alonso A. Compartmentalization of Ceramide Signaling: Physical Foundations and Biological Effects. J. Cell. Physiol. 2000; 184: 285–300
   PubMed Web of Science ®Google Scholar
• Liu B., Andrieu-Abadie N., Levade T., Zhang P., Obeid L.M., Hannun Y.A. Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death. J. Biol. Chem. 1998; 273: 11313–11320
   PubMed Web of Science ®Google Scholar
• Jaffrézou J.P., Maestre N., De Mas-Mansat V., Bezombes C., Levade T., Laurent G. Positive Feedback Control of Neutral Sphingomyelinase Activity by Ceramide. FASEB J. 1998; 12: 999–1006
   PubMed Web of Science ®Google Scholar
• Ardail D., Popa I., Alcantara K., Pons A., Zanetta J.P., Louisot P., Thomas L., Portoukalian J. Occurrence of Ceramides and Neutral Glycolipids with Unusual Long-Chain Base Composition in Purified Rat Liver Mitochondria. FEBS Lett. 2001; 488: 160–164
   PubMed Web of Science ®Google Scholar
• Xia P., Gamble J.R., Wang L.J., Pitson S.M., Moretti P.A.B., Wattenberg B.W., D'Andrea R.J., Vadas M.A. An Oncogenic Role of Sphingosine Kinase. Curr. Biol. 2000; 10: 1527–1530
   PubMed Web of Science ®Google Scholar
• Radin N.S. Chemotherapy by Slowing Glucosphingolipid Synthesis. Biochem. Pharmacol. 1999; 57: 589–595
   PubMed Web of Science ®Google Scholar
• Zeng G.C., Gao L.Y., Birkle S., Yu R.K. Suppression of Ganglioside GD3 Expression in a Rat F-11 Tumor Cell Line Reduces Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Production. Cancer Res. 2000; 60: 6670–6676
   PubMed Web of Science ®Google Scholar
• Hakomori S. Aberrant Glycosylation in Cancer Cell Membranes as Focused on Glycolipids: Overview and Perspectives. Cancer Res. 1985; 45: 2405–2414
   PubMed Web of Science ®Google Scholar
• Coroneos E., Martinez M., McKenna S., Kester M. Differential Regulation of Sphingomyelinase and Ceramidase Activities by Growth Factors and Cytokines—Implications for Cellular Proliferation and Differentiation. J. Biol. Chem. 1995; 270: 23305–23309
   PubMed Web of Science ®Google Scholar
• Panetti T.S., Nowlen J., Mosher D.F. Sphingosine-1-phosphate and Lysophosphatidic Acid Stimulate Endothelial Cell Migration. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1013–1019
   PubMed Web of Science ®Google Scholar
• Alessandri G., De Cristan G., Ziche M., Cappa A.P., Gullino P.M. Growth and Motility of Microvascular Endothelium Are Modulated by the Relative Concentration of Gangliosides in the Medium. J. Cell. Physiol. 1992; 151: 23–28
   PubMed Web of Science ®Google Scholar
• Manfredi M.G., Lim S., Claffey K.P., Seyfried T.N. Gangliosides Influence Angiogenesis in an Experimental Mouse Brain Tumor. Cancer Res. 1999; 59: 5392–5397
   PubMed Web of Science ®Google Scholar
• Bhunia A.K., Han H., Snowden A., Chatterjee S. Redox-Regulated Signaling by Lactosylceramide in the Proliferation of Human Aortic Smooth Muscle Cells. J. Biol. Chem. 1997; 272: 15642–15649
   PubMed Web of Science ®Google Scholar
• Witt C.J., Gabel S.P., Meisinger J., Werra G., Liu S.W., Young M.R.I. Interrelationship Between Protein Phosphatase-2A and Cytoskeletal Architecture During the Endothelial Cell Response to Soluble Products Produced by Human Head and Neck Cancer. Otolaryngol. Head Neck Surg. 2000; 122: 721–727
   PubMed Web of Science ®Google Scholar
• Chalfant C.E., Kishikawa K., Mumby M.C., Kamibayashi C., Bielawska A., Hannun Y.A. Long Chain Ceramides Activate Protein Phosphatase-1 and Protein Phosphatase-2A. Activation Is Stereospecific and Regulated by Phosphatidic Acid. J. Biol. Chem. 1999; 274: 20313–20317
   PubMed Web of Science ®Google Scholar
• Chatterjee S. Sphingolipids in Atherosclerosis and Vascular Biology. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1523–1533
   PubMed Web of Science ®Google Scholar
• Memon R.A., Holleran W.M., Moser A.H., Seki T., Uchida Y., Fuller J., Shigenaga J.K., Grunfeld C., Feingold K.R. Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1257–1265
   PubMed Web of Science ®Google Scholar
• van Helvoort A., Smith A.J., Sprong H., Fritsche I., Schinkel A.H., Borst P., van Meer G. MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine. Cell 1996; 87: 507–517
   PubMed Web of Science ®Google Scholar
• Raggers R.J., van Helvoort A., Evers R., van Meer G. The Human Multidrug Resistance Protein MRP1 Translocates Sphingolipid Analogs Across the Plasma Membrane. J. Cell. Sci. 1999; 112: 415–422
   PubMed Web of Science ®Google Scholar
• Lala P., Ito S., Lingwood C.A. Retroviral Transfection of Madin–Darby Canine Kidney Cells with Human MDR1 Results in a Major Increase in Globotriaosylceramide and 105- to 106-fold Increased Cell Sensitivity to Verocytotoxin. Role of P-Glycoprotein in Glycosphingolipid Synthesis. J. Biol. Chem. 2000; 275: 6246–6251
   PubMed Web of Science ®Google Scholar
• Radin N.S. Killing Cancer Cells by Poly-drug Elevation of Ceramide Levels: A Hypothesis Whose Time Has Come?. Eur. J. Biochem. 2001; 268: 193–204
   PubMedGoogle Scholar
• Liu Y.Y., Han T.Y., Giuliano A.E., Cabot M.C. Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells. J. Biol. Chem. 1999; 274: 1140–1146
   PubMed Web of Science ®Google Scholar
• Lucci A., Cho W.I., Han T.Y., Giuliano A.E., Morton D.L., Cabot M.C. Glucosylceramide: A Marker for Multiple-Drug Resistant Cancers. Anticancer Res. 1998; 18(1B)475–480
   PubMed Web of Science ®Google Scholar
• Chou K.H., Jungalwala F.B. Neutral Glycosphingolipids and Ceramide Composition of Ethylnitrosourea-Induced Rat Neural Tumors: Accumulation of Ceramide in Tumors. J. Neurochem. 1981; 36: 394–401
   PubMed Web of Science ®Google Scholar
• Tepper A.D., Diks S.H., van Blitterswijk W.J., Borst J. Glucosylceramide Synthase Does Not Attenuate the Ceramide Pool Accumulating During Apoptosis Induced by CD95 or Anti-cancer Regimens. J. Biol. Chem. 2000; 275: 34810–34817
   PubMed Web of Science ®Google Scholar
• Liu Y.-Y., Han T.-Y., Giuliano A.E., Hansen N., Cabot M.C. Uncoupling Ceramide Glycosylation by Transfection of Glucosylceramide Synthase Antisense Reverses Adriamycin Resistance. J. Biol. Chem. 2000; 275: 7138–7143
   PubMed Web of Science ®Google Scholar
• Komori H., Ichikawa S., Hirabayashi Y., Ito M. Regulation of UDP-Glucose:Ceramide Glucosyltransferase-1 by Ceramide. FEBS Lett. 2000; 475: 247–250
   PubMed Web of Science ®Google Scholar
• Inokuchi J., Jimbo M., Momosaki K., Shimeno H., Nagamatsu A., Radin N.S. Inhibition of Experimental Metastasis of Murine Lewis Lung Carcinoma by an Inhibitor of Glucosylceramide Synthase and Its Possible Mechanism of Action. Cancer Res. 1990; 50: 6731–6737
   PubMed Web of Science ®Google Scholar
• Deng W., Li R.X., Ladisch S. Influence of Cellular Ganglioside Depletion on Tumor Formation. J. Natl Cancer Inst. 2000; 92: 912–917
   PubMed Web of Science ®Google Scholar
• Ladisch S., Kitada S., Hays E.F. Gangliosides Shed by Tumor Cells Enhance Tumor Formation in Mice. J. Clin. Investig. 1987; 79: 1879–1882
   PubMed Web of Science ®Google Scholar
• McKallip R., Li R.X., Ladisch S. Tumor Gangliosides Inhibit the Tumor-Specific Immune Response. J. Immunol. 1999; 163: 3718–3726
   PubMed Web of Science ®Google Scholar
• Shurin G.V., Shurin M.R., Bykovskaia S., Shogan J., Lotze M.T., Barksdale E.M. Neuroblastoma-Derived Gangliosides Inhibit Dendritic Cell Generation and Function. Cancer Res. 2001; 61: 363–369
   PubMed Web of Science ®Google Scholar
• Shukla G.S., Shukla A., Radin N.S. Gangliosides Inhibit Glucosylceramide Synthase: Possible Role in Ganglioside Therapy. J. Neurochem. 1991; 56: 2125–2132
   PubMed Web of Science ®Google Scholar
• Lee L., Abe A., Shayman J.A. Improved Inhibitors of Glucosylceramide Synthase. J. Biol. Chem. 1999; 274: 14662–14669
   PubMed Web of Science ®Google Scholar
• Rosenwald A.G., Pagano R.E. Effects of the Glycosphingolipid Synthesis Inhibitor, PDMP, on Lysosomes in Cultured Cells. J. Lipid Res. 1994; 35: 1232–1240
   PubMed Web of Science ®Google Scholar
• Selzner M., Bielawska A., Morse M.A., Rudiger H.A., Sindram D., Hannun Y.A., Clavien P.A. Induction of Apoptotic Cell Death and Prevention of Tumor Growth by Ceramide Analogues in Metastatic Human Colon Cancer. Cancer Res. 2001; 61: 1233–1240
   PubMed Web of Science ®Google Scholar